Profile
Russell E.
Phares was a Director of Advanced Proteome Therapeutics Corp.
He served as Chief Executive Officer of CooperVision Pharmaceuticals and Cooper Laboratories for 10 years.
Dr. Phares received a PhD in Pharmacy from Purdue University.
He was an Assistant Professor of Pharmacy at the University of Florida.
Former positions of Russell E. Phares
| Companies | Position | End |
|---|---|---|
| ADVANCED PROTEOME THERAPEUTICS CORPORATION | Director/Board Member | 2008-10-10 |
CooperVision, Inc.
 CooperVision, Inc. Medical SpecialtiesHealth Technology CooperVision, Inc. engages in the manufacture of contact lenses. It offers monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. The firm’s products include MyDay; clariti 1day , Biofinity , Proclear and Avaira family. The company was founded in 1950 and is headquartered in Victor, NY. | President | - |
| CooperVision Pharmaceuticals, Inc. | President | - |
Training of Russell E. Phares
| Purdue University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ADVANCED PROTEOME THERAPEUTICS CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
| CooperVision Pharmaceuticals, Inc. | |
CooperVision, Inc.
CooperVision, Inc. Medical SpecialtiesHealth Technology CooperVision, Inc. engages in the manufacture of contact lenses. It offers monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. The firm’s products include MyDay; clariti 1day , Biofinity , Proclear and Avaira family. The company was founded in 1950 and is headquartered in Victor, NY. | Health Technology |
- Stock Market
- Insiders
- Russell E. Phares
